Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease
1Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Therapeutic Advances in Respiratory Disease
|December 30, 2016
Summary
Novel macrolides without antibiotic effects show promise for treating chronic obstructive pulmonary disease (COPD) by reducing inflammation. Further research is needed to identify patient subgroups and explore combination therapies.
Area of Science:
- Pulmonology
- Pharmacology
- Immunology
Background:
- Chronic inflammation is key in chronic obstructive pulmonary disease (COPD) pathogenesis.
- Current anti-inflammatory treatments for COPD are limited.
- Immunologic mechanisms are increasingly recognized in COPD development.
Purpose of the Study:
- To explore the potential of macrolides as anti-inflammatory agents for COPD treatment.
- To investigate novel macrolides with immune-modulating effects but lacking antibiotic properties.
- To assess macrolides' role in managing COPD exacerbations.
Main Methods:
- Review of existing clinical studies on long-term macrolide use in COPD.
- Analysis of macrolides' anti-inflammatory and immune-modulating properties.
- Exploration of potential therapeutic strategies involving macrolides.
Main Results:
- Long-term macrolide use has been shown to decrease COPD exacerbation frequency.
- Specific patient subgroups benefiting most from macrolide treatment require identification.
- Concerns exist regarding adverse events and antimicrobial resistance with long-term macrolide use.
Conclusions:
- Novel macrolides offer a promising anti-inflammatory approach for COPD without contributing to antibiotic resistance.
- Identifying optimal patient subgroups is crucial for effective macrolide therapy.
- Combining macrolides with other anti-inflammatory drugs presents a potential new treatment strategy for COPD.
More Related Videos
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
01:24Chronic Obstructive Pulmonary Disease
2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K